Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Neuralgia

1-methyl-3-isobutylxanthine has been researched along with Neuralgia in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, T1
Saito, O1
Aoe, T1
Bartolozzi, A1
Sarva, J1
Zhou, J1
Kozikowski, A1
Wroblewska, B1
Bzdega, T1
Neale, JH1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Neuralgia

ArticleYear
Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
    The European journal of neuroscience, 2007, Volume: 25, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Carrageenan; Cells, Cultured; Cerebellum; Cricetinae; Cricetul

2007